ZIVO Bioscience Increases Credit Line To $17.5 Million, Finds Early Success In $5 Million Capital Funding Initiative

KEEGO HARBOR, MI ZIVO, (Marketwired Nov 2, 2016) ZIVO Bioscience, Inc. (OTCQB: ZIVO) announces today that from July 1, 2016 to date, the Company has received $2 million in new capital funding as part of its Q3/Q4 capital funding initiative. This brings the total of new funding to $3.25 million year to date. In related news, the ZIVO Board of Directors recently approved an increase in the available credit line from HEP Investments, LLC to $17.5 million. To accommodate
http://bit.ly/2fES5bA